Health and Fitness Health and Fitness
Tue, July 31, 2012
Mon, July 30, 2012

Analyst Research on Hologic Inc. and Medtronic Inc. - New Products Propelling Medical Equipment Companies


Published on 2012-07-30 05:38:11 - Market Wire
  Print publication without navigation


July 30, 2012 08:25 ET

Analyst Research on Hologic Inc. and Medtronic Inc. - New Products Propelling Medical Equipment Companies

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jul 30, 2012) - [ www.StockCall.com ] offers free research on Hologic Inc. (NASDAQ: [ HOLX ]) and Medtronic Inc. (NYSE: [ MDT ]) from the Medical Appliances & Equipment industry. Access these reports by clicking on the links below or by copy and pasting those to your address bar.

[ www.StockCall.com/reports ]

The medical appliances & equipment industry has performed relatively well through the downturn and subsequent slow recovery, as many of its products fall into the essential purchases category. The industry and companies such as Hologic Inc. and Medtronic Inc. could also receive a boost from the upcoming increase in insured Americans, following the upholding of the Obamacare legislation.

StockCall.com is an online platform where investors doing their due-diligence on the Medical Appliances & Equipment industry can have easy and free access to our analyst research and opinions on Hologic Inc. and Medtronic Inc. To see how companies in this industry have grown over the past years and how they are expected to perform in the future, please visit the link below.

[ www.StockCall.com ]

Individual companies have also been doing a good job of developing and releasing new products. Medtronic recently stated that it has begun the worldwide launch of its CD HORIZON® SOLERA™ 5.5/6.0 System, part of the CD HORIZON® group of fixation devices. The product provides spinal stabilization and correction. Register now to have free access to our report on Medtronic Inc., and to do so please click the link below.

[ www.StockCall.com/MDT300712.pdf ]

Hologic has also been active as of late, announcing that the Netherlands Society of Pathology approved the use of the company's Cervista HPV HR test, used to detect human papillomavirus. Hologic is set to announce its fiscal 3rd quarter results on Monday July 30th. Investors and shareholders of Hologic Inc. can simply register for our complimentary reports by clicking on the link below.

[ www.StockCall.com/HOLX300712.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.


Contributing Sources